Brown Advisory’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $57M | Buy |
108,229
+180
| +0.2% | +$101K | 0.09% | 177 |
|
|
2026
Q1 | $60.7M | Buy |
108,049
+477
| +0.4% | +$306K | 0.1% | 156 |
|
|
2025
Q4 | $72.8M | Sell |
107,572
-1,245
| -1% | -$848K | 0.1% | 152 |
|
|
2025
Q3 | $69.5M | Buy |
108,817
+56
| +0.1% | +$34K | 0.09% | 159 |
|
|
2025
Q2 | $58.3M | Sell |
108,761
-10,408
| -9% | -$4.98M | 0.08% | 178 |
|
|
2025
Q1 | $50M | Sell |
119,169
-4,932
| -4% | -$2.14M | 0.07% | 184 |
|
|
2024
Q4 | $51.3M | Sell |
124,101
-967,797
| -89% | -$425M | 0.07% | 202 |
|
|
2024
Q3 | $552M | Sell |
1,091,898
-63,793
| -6% | -$31M | 0.69% | 37 |
|
|
2024
Q2 | $563M | Sell |
1,155,691
-26,639
| -2% | -$13.4M | 0.74% | 37 |
|
|
2024
Q1 | $638M | Buy |
1,182,330
+25,271
| +2% | +$13.8M | 0.85% | 27 |
|
|
2023
Q4 | $642M | Sell |
1,157,059
-4,065
| -0.4% | -$1.91M | 0.9% | 24 |
|
|
2023
Q3 | $508M | Buy |
1,161,124
+24,741
| +2% | +$12.3M | 0.83% | 29 |
|
|
2023
Q2 | $571M | Sell |
1,136,383
-6,592
| -0.6% | -$3.16M | 0.89% | 24 |
|
|
2023
Q1 | $572M | Buy |
1,142,975
+23,019
| +2% | +$11M | 0.97% | 21 |
|
|
2022
Q4 | $457M | Sell |
1,119,956
-92,072
| -8% | -$35.7M | 0.85% | 25 |
|
|
2022
Q3 | $395M | Buy |
1,212,028
+170,834
| +16% | +$62.8M | 0.77% | 35 |
|
|
2022
Q2 | $365M | Sell |
1,041,194
-69,160
| -6% | -$28.2M | 0.69% | 37 |
|
|
2022
Q1 | $607M | Buy |
1,110,354
+30,727
| +3% | +$16.2M | 0.91% | 26 |
|
|
2021
Q4 | $711M | Buy |
1,079,627
+84,251
| +8% | +$52.9M | 0.88% | 30 |
|
|
2021
Q3 | $619M | Buy |
995,376
+30,902
| +3% | +$20.8M | 0.91% | 30 |
|
|
2021
Q2 | $609M | Buy |
964,474
+57,830
| +6% | +$31.9M | 0.92% | 28 |
|
|
2021
Q1 | $444M | Buy |
906,644
+49,461
| +6% | +$24.8M | 0.76% | 37 |
|
|
2020
Q4 | $428M | Buy |
857,183
+122,300
| +17% | +$54.7M | 0.76% | 38 |
|
|
2020
Q3 | $289M | Buy |
734,883
+89,356
| +14% | +$33M | 0.6% | 44 |
|
|
2020
Q2 | $213M | Buy |
645,527
+124,565
| +24% | +$36.1M | 0.5% | 49 |
|
|
2020
Q1 | $126M | Buy |
520,962
+104,685
| +25% | +$27.3M | 0.39% | 58 |
|
|
2019
Q4 | $109M | Buy |
416,277
+25,755
| +7% | +$6.79M | 0.28% | 75 |
|
|
2019
Q3 | $106M | Buy |
390,522
+59,448
| +18% | +$16.5M | 0.3% | 67 |
|
|
2019
Q2 | $91.2M | Buy |
331,074
+44,066
| +15% | +$10.9M | 0.26% | 74 |
|
|
2019
Q1 | $64.2M | Buy |
287,008
+64,492
| +29% | +$13.3M | 0.18% | 104 |
|
|
2018
Q4 | $41.4M | Buy |
222,516
+16,334
| +8% | +$3.35M | 0.14% | 141 |
|
|
2018
Q3 | $51.5M | Buy |
206,182
+14,477
| +8% | +$3.51M | 0.15% | 132 |
|
|
2018
Q2 | $41.8M | Buy |
191,705
+4,266
| +2% | +$879K | 0.13% | 148 |
|
|
2018
Q1 | $35.9M | Sell |
187,439
-68,863
| -27% | -$12.7M | 0.12% | 163 |
|
|
2017
Q4 | $40.1M | Sell |
256,302
-2,849
| -1% | -$448K | 0.13% | 154 |
|
|
2017
Q3 | $40.3M | Sell |
259,151
-345,408
| -57% | -$54.6M | 0.13% | 149 |
|
|
2017
Q2 | $97.6M | Buy |
604,559
+163,547
| +37% | +$26.6M | 0.3% | 74 |
|
|
2017
Q1 | $68.2M | Sell |
441,012
-259,044
| -37% | -$35.7M | 0.23% | 94 |
|
|
2016
Q4 | $82.1M | Sell |
700,056
-16,684
| -2% | -$1.9M | 0.29% | 76 |
|
|
2016
Q3 | $80.8M | Sell |
716,740
-40,952
| -5% | -$4.32M | 0.28% | 74 |
|
|
2016
Q2 | $70.4M | Buy |
757,692
+21,651
| +3% | +$1.86M | 0.25% | 77 |
|
|
2016
Q1 | $57.6M | Buy |
736,041
+12,313
| +2% | +$887K | 0.2% | 80 |
|
|
2015
Q4 | $52.8M | Buy |
723,728
+26,847
| +4% | +$1.92M | 0.18% | 90 |
|
|
2015
Q3 | $51.7M | Buy |
696,881
+67,379
| +11% | +$4.83M | 0.18% | 87 |
|
|
2015
Q2 | $40.4M | Sell |
629,502
-57,160
| -8% | -$3.96M | 0.13% | 112 |
|
|
2015
Q1 | $53M | Sell |
686,662
-22,148
| -3% | -$1.72M | 0.17% | 92 |
|
|
2014
Q4 | $52.5M | Buy |
708,810
+168,082
| +31% | +$11.8M | 0.17% | 98 |
|
|
2014
Q3 | $31.9M | Sell |
540,728
-9,410
| -2% | -$595K | 0.1% | 145 |
|
|
2014
Q2 | $36.7M | Sell |
550,138
-33,982
| -6% | -$2.16M | 0.12% | 128 |
|
|
2014
Q1 | $35.5M | Sell |
584,120
-6,016
| -1% | -$358K | 0.11% | 130 |
|
|
2013
Q4 | $31.4M | Sell |
590,136
-7,776,148
| -93% | -$409M | 0.1% | 140 |
|
|
2013
Q3 | $417M | Buy |
8,366,284
+375,818
| +5% | +$18.1M | 1.49% | 27 |
|
|
2013
Q2 | $358M | Buy |
+7,990,466
| New | +$349M | 1.44% | 28 |
|
Other funds holding IDXX
Brown Advisory's IDXX Position: Q2 2026 in Review
Brown Advisory increased its Idexx Laboratories (IDXX) stake by 0.17% in Q2 2026, buying an estimated $101K and bringing the position to 108,229 shares worth $57M. The position accounts for 0.09% of the portfolio, ranked #177.
Brown Advisory first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $711M in Q4 2021. 1,294 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Brown Advisory held 108,229 shares of Idexx Laboratories worth $57M as of Q2 2026.
- Brown Advisory bought 180 Idexx Laboratories shares in Q2 2026, an estimated $101K.
- Idexx Laboratories made up 0.09% of Brown Advisory's portfolio in Q2 2026, its #177 holding.
- Brown Advisory first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Brown Advisory's Idexx Laboratories position peaked at $711M in Q4 2021.
- 1,294 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.